Drug Search Results
More Filters [+]

Olaflur

Alternative Names: olaflur, amine fluoride
Latest Update: 2024-02-09
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Austria | Belgium | Colombia | Dominican Republic | Ecuador | Finland | Germany | Hungary | Italy | Mexico | Peru | Portugal | Slovenia | United Arab Emirates

Approved Indications: None

Known Adverse Events: None

Company: Colgate Palmolive
Company Location: NEW YORK NY 10022
Company CEO: Noel R. Wallace
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Olaflur

Countries in Clinic: Italy

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Dental Plaque

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CRO-2020-12-PGN-MMW-ITA-YPZ

P3

Completed

Dental Plaque

2021-09-24

38%

CRO-2020-12-PGN-MMW-ITA-YPZ

P3

Completed

Dental Plaque

2021-09-24

38%

Recent News Events